Dash Capital Corp. and Simply Solventless Concentrates Ltd. (SSC) to provide an update on the previously announced business combination, which will constitute the Qualifying Transaction of Dash (the Transaction). on August 9, 2021, Dash, SSC and 2366191 Alberta Ltd. (Dash Subco), a wholly owned subsidiary of Dash, entered into an amalgamation agreement dated August 6, 2021 (the Amalgamation Agreement), which, among other things, sets forth the terms and conditions of the Transaction. It is expected that the board of directors and management of the Resulting Issuer will be comprised of the following individuals: Jeffrey Swainson ­ President, Chief Executive Officer and Director: Prior to co-founding SSC, Jeff was Co-Founder and Chief Financial Officer of SugarBud Craft Growers Corp. James Nerland ­ Chief Financial Officer: Prior to SSC, James led Decibel Cannabis Company's (Decibel) finance team in the areas of financial reporting, tax, M&A accounting, post-implementation ERP system development and integration, and internal controls. Gord Cameron ­ Corporate Secretary: Gord is currently a partner with McCarthy Tétrault LLP and has been a
practicing lawyer in Alberta since 2009. Tara Johnson-Ouellette ­ Director: Tara most recently served as Vice President, Compliance and Regulatory Affairs
with SugarBud, where she was largely responsible for the on-budget
construction and licensing of its vertical cannabis
cultivation facility. William (Bill) MacDonald ­ Director: Bill has over 40 years of deal making, financing and capital markets
experience. He has extensive experience with publicly listed companies
having been involved in four TSXV recapitalizations in the last five years and three initial public offering filings on the Canadian
Securities Exchange. Colin Davison ­ Director: Colin is currently President and Chairman of McIntyre Creek Cannabis
Inc., a leading producer of fresh frozen and dried and cured outdoor
cannabis, and Chief Executive Officer of NOVEM Pharmaceuticals Inc. Hugh Porter ­ Director: Hugh is currently the Chief Executive Officer of Battle River Pharmaceuticals.